📰 Alkermes News
Page 25 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
August 25, 2023
Important Facts About Alkermes – A Must-Know for Investors
August 24, 2023
Major players in the olanzapine market are Aurobindo Pharma Ltd, Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical...
August 23, 2023
DURHAM, N.C.--(BUSINESS WIRE)--BioAesthetics Corporation announced today the appointment of Mr. Joseph Nixon to its Board of Directors. Mr. Nixon brings over 25 years of life sciences investing and operating experience to BioAesthetics. He currently serves as Chief Financial Officer for Locus Biosciences, a biopharm...
August 17, 2023
Pictet Asset Management SA grew its holdings in Alkermes plc (NASDAQ:ALKS – Free Report) by 279.0% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 2,772,291 shares of the company’s stock after acquiring an additional 2,040,819 shares during the quarter. Pictet Asset Management SA owned […]
August 15, 2023
Premier database and directory of PR firms & public relations agencies. Find the firm that best suits your needs.
August 12, 2023
Integral Health Asset Management LLC purchased a new position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) in the first quarter, Holdings Channel.com reports. The institutional investor purchased 179,000 shares of the company’s stock, valued at approximately $5,046,000. Other large investors have also modified their holdings of the company. Cibc World Markets Corp acquired […]
August 11, 2023
The safety and efficacy achieved with the combination of savolitinib and durvalumab vs standard-of-care sunitinib or durvalumab monotherapy will be evaluated in patients with MET-driven papillary renal cell carcinoma in the phase 3 SAMETA trial.
August 10, 2023
Biotech is still booming, if you pick the right biotech stocks.
August 9, 2023
With its stock down 9.6% over the past three months, it is easy to disregard Alkermes (NASDAQ:ALKS). But if you pay...
August 8, 2023
Eagle Asset Management Inc. increased its position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 25.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 802,279 shares of the company’s stock after acquiring an additional 161,434 shares during the period. Eagle Asset Management […]